Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase NA 7Phase 1/2 3Phase 1 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 7Stomach Neoplasms 3Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Multiple Myeloma 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Radiosurgery 6pembrolizumab 4Carboplatin 3atezolizumab 2aldesleukin 2Paclitaxel 2Nivolumab 2Cyclophosphamide 2osimertinib 1durvalumab 1avelumab 1amatuximab 1Vitamin A 1Tobacco Use Cessation Devices 1Thoracic Surgical Procedures 1Taxes 1Radiotherapy 1Radiation Dose Hypofractionation 1RXDX-106 1Proton Therapy 1Pemetrexed 1Optical Fibers 1Oncolytic Virotherapy 1Itraconazole 1Interleukin-2 1Fluorodeoxyglucose F18 1Ethiodized Oil 1Erlotinib Hydrochloride 1Docetaxel 1Dihematoporphyrin Ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Non-Small-Cell Lung × Fluorodeoxyglucose F18 × Clear all
NCT01666353 2019-02-08

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Completed
20 enrolled
DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡